Home

Intellectual Property

Technology Transfer: Benefits from Biotech

This side-event, organized by the Biotechnology Industry Organization (BIO) and cosponsored by the Association of University Technology Managers (AUTM), provided an overview on the key elements at play in establishment an enabling environment for transfer of technology to support the full implementation of CBD objectives and priorities.

Milestones in 2006-2007

What happens in Washington influences biotechnology progress every bit as much as what happens on Wall Street or in the lab.

The Myth of the Anticommons

The theory claiming that the over-patenting of biotechnology research hinders the research and development of new treatments is not supported by empirical evidence.

BIO Bioprospecting Guidelines
Cloning Fact Sheet

On July 23rd, the House passed by voice vote an amendment on human patenting offered by Dave Weldon (R-Fla.) as part of the Commerce-Justice-State appropriations bill (H.R. 2799).

Fact sheet on S. 54, the Greater Access to Affordable Pharmaceuticals Act of 2003

In the early weeks of the 108th Congress, two Senate bills, S. 54 and S. 7, were introduced that embrace the "Greater Access to Affordable Pharmaceuticals Act of 2003" (GAAP), formerly known in the 107th Congress as S. 812

FDA Proposed Rule to Revise Hatch-Waxman Regulations

On October 24th the FDA published proposed regulations that affect implementation of the Hatch-Waxman law. These changes in part respond to recommendations in a July 2002 Federal Trade Commission (FTC) report and a Citizen Petition filed with the FDA by the FTC in May 2001.

Fact Sheet on S. 812 McCain/Schumer

Last week, the Senate Health, Education, Labor and Pensions (HELP) Committee marked-up legislation - The Edwards/Collins substitute to S. 812 - The "Greater Access to Affordable Pharmaceuticals Act of 2001" - that raises serious concerns for members of the Biotechnology Industry Organization (BIO).

Letters, Testimony & Comments

BIO Comments on Peruvian Biologics and Biosimilars Regulations
March 21 2013
BIO commends the Government of Peru for its endeavor to create a pathway for the approval of biological and biotechnological products....
BIO Comments on Colombia Biologics and Biosimilars Regulations
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
2013 Special 301 Submission: BIO Provides Input on Biotech IP Challenges Around the Globe
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
BIO Comments on INPI Guidelines for Examination of Biotechnology Patent Applications in Brazil
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
BIO Comments on Brazil's ANVISA Public Consultation N°66/2012
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
More Letters, Testimony & Comments →

Press Releases

BIO Shares U.S. Trade Representative's International Patent Concerns
May 2 2013
Washington, D.C. (May 2, 2013) The Biotechnology Industry Organization (BIO) today expressed concern over specific...
Indian Supreme Court Ruling Negatively Affects Innovation
April 8 2013
Washington, D.C. (April 8, 2013) –  The Biotechnology Industry Organization (BIO) issued the following...
Innovation and The Supreme Court: Two Cases to Watch
February 11 2013
  WHAT: An inside look at two cases facing the Supreme Court of the United States: Bowman v....
BIO and ASTA Welcome Continued Support for the Accord
January 15 2013
Washington, D.C. — The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA...
BIO Study Quantifies Economic Contribution of University & Non-Profit Inventions
June 21 2012
Washington, D.C. (June 21, 2012) – The Biotechnology Industry Organization (BIO) released a report on the...
More Press Releases →